Search Results
May 07, 2026, 16:03 ET BioLife Solutions Reports First Quarter 2026 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market,
More news about: BioLife Solutions, Inc.
Apr 23, 2026, 16:03 ET BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2026 first
More news about: BioLife Solutions, Inc.
Apr 21, 2026, 16:15 ET BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced it has received
More news about: BioLife Solutions, Inc.
Feb 26, 2026, 16:03 ET BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, today
More news about: BioLife Solutions, Inc.
Feb 17, 2026, 08:04 ET BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2025 fourth
More news about: BioLife Solutions, Inc.
Feb 12, 2026, 08:03 ET BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a
More news about: BioLife Solutions, Inc.
Jan 12, 2026, 08:03 ET BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market,
More news about: BioLife Solutions, Inc.
Nov 20, 2025, 08:04 ET BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced the opening
More news about: BioLife Solutions, Inc.
Nov 17, 2025, 07:15 ET BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced that management
More news about: BioLife Solutions, Inc.
Nov 06, 2025, 16:03 ET BioLife Solutions Reports Third Quarter 2025 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market,
More news about: BioLife Solutions, Inc.
Oct 23, 2025, 16:03 ET BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's
More news about: BioLife Solutions, Inc.
Oct 07, 2025, 08:04 ET BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools for the cell and gene therapy ("CGT") market, announces the
More news about: BioLife Solutions, Inc.
Aug 07, 2025, 16:03 ET BioLife Solutions Reports Second Quarter 2025 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, announces
More news about: BioLife Solutions, Inc.
Jul 28, 2025, 08:05 ET BioLife Solutions Makes Strategic Investment in Pluristyx
BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced that as part
More news about: BioLife Solutions, Inc.
Jul 24, 2025, 16:05 ET BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's
More news about: BioLife Solutions, Inc.